Diagnostic methods for sars-cov-2 infection
Main Article Content
Abstract
In December 2019, the SARS-CoV-2 virus was identified for the first time, whose rapid global spread put the entire world in a state of emergency, leading humans to an unprecedented situation with no immediate history. The main purpose of this review is to describe the diagnostic methods currently used to identify SARS-CoV-2 infection. The clinical manifestations and the imaging spectrum of the disease are nonspecific and do not allow an accurate diagnosis to be made. For this reason, an appropriate respiratory sampling at the right time and anatomical site is essential for an accurate diagnosis of COVID-19. The most widely used sampling technique is nasopharyngeal swab, and the most reliable diagnostic test is by reverse transcription followed by real-time polymerase chain reaction (RT-PCR). However, there are other molecular techniques, as well as serological tests to detect antibodies or antigenic fragments of SARS-CoV-2. Beyond the diagnostic precision, it is important to take into account the baseline probability (pre-test) to correctly interpret the result obtained and isolate those possible false negatives. In order to avoid saturation of the health system, it is essential to have accurate information and diagnostic methods to detect outbreaks of infection in early stages and to reduce communitary transmission, making effective use of the various diagnostic resources. Coronavirus infections/diagnosis, viral/diagnosis, pandemics, clinical laboratory techniques, real-time polymerase chain reaction, antigens, viral/analysis.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Huang C, Wang Y, Li X, et al. Clinical features of patients infec-ted with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506.
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19, 11 March 2020 [Inter-net].Geneva: WHO; 2020 [citado 2020 mar 15]. Disponible en: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.
World Health Organization. Transmission of SARS-CoV-2: im-plications for infection prevention precautions [Internet]. Geneva: WHO; 2020 [citado 2020 jul 12]. Disponible en: https://www.who.int/newsroom/commentaries/detail/transmission-of-sars-cov-2-impli-cations-for-infection-prevention-precautions.
World Health Organization. Coronavirus disease (COVID-19) situation reports [Internet]. Geneva: WHO; 2020 [citado 2020 jul 13]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Argentina. Boletín Oficial de la República Argentina. Aislamienoto social preventivo y obligatorio. Decreto 493/2020 [Internet]. Buenos Aires: Presidencia; 2020 mayo 24 [citado 2020 mayo 24]. Disponible en: https://www.boleti-noficial.gob.ar/detalleAviso/prime-ra/229716/20200525.
Argentina. Ministerio de Salud. Nuevo coronavirus 2019: reporte diario vespertino no. 242 [internet]. Buenos Aires: el Ministerio; 2020 jul 13 [citado 2020 jul 13]. Disponible en: https://www.argentina.gob.ar/sites/default/files/13-07-20-reporte-vespertino-covid-19.pdf.
Argentina. Ministerio de Salud de la Nación. Guía para el fortalecimiento de la vigilancia de la salud en el nivel local [Internet]. Buenos Aires: el Ministerio; 2013 [citado 2020 mayo 26]. Disponible en: http://www.msal.gob.ar/images/stories/epidemiologia/pdf/guia-c2_vigilan-cia.pdf.
Winichakoon P, Chaiwarith R, Liws-risakun C, et al. Negative nasopharyn-geal and oropharyngeal swabs do not rule out COVID-19. J Clin Microbiol. 2020; 58(5):e00297-20.
Organización Mundial de la Sa-lud. Preguntas y respuestas sobre la enfermedad por coronavirus (COVID-19) [Internet]. [Ginebra]: OMS; 2020 [citado 2020 mayo 29]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/advice-for-public/q-a-coronaviruses.
Struyf T, Deeks JJ, Dinnes J, et al. Signs and symptoms to de-termine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020; 7(7):CD013665.
Argentina. Ministerio de Salud. Laboratorio: toma de muestras [Inter-net]. Buenos Aires: el Ministerio; 2020 [consulta 2020 jun 19]. Disponible en: https://www.argentina.gob.ar/salud/coronavirus-COVID-19/laboratorio.
Centers for Disease Control and Prevention. Information for laboratories about Coronavirus (COVID-19) [Internet]. Atlanta, GA: CDC; 2020 [citado 2020 mayo 24]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/lab/index.html.
Wang W, Xu Y, Gao R, et al. De-tection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020; 323(18):1842-1844.
To KK-W, Tsang OT-Y, Yip CC-Y, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020; 71(15):841-843.
Tang YW, Schmitz JE, Persing DH, et al. Laboratory diagnosis of COVID-19 infection: current issues and challenges. J Clin Microbiol. 2020; 58(6):e00512-20.
Loeffelholz MJ, Tang YW. Labo-ratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020; 9(1):747-756.
To KK-W, Tsang OT-Y, Leung WS, et al. Temporal profiles of vi-ral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020; 20(5):565-574.
Cheng PK, Wong DA, Tong LK, et al. Viral shedding patterns of co-ronavirus in patients with probable severe acute respiratory syndrome. Lancet. 2004; 363(9422):1699-1700.
Miller S, Chiu C, Rodino KG, Miller MB. Point-counterpoint: should we be performing metageno-mic next-generation sequencing for infectious disease diagnosis in the clinical laboratory? J Clin Microbiol. 2020; 58(3):e01739-19.
Consejo Nacional de Investi-gaciones Científicas y Técnicas. Nuevos hallazgos de secuenciación de genomas virales de SARS-CoV2 realizado por científicas y científicos argentinos [Internet]. Buenos Aires: CONICET; 2020 abr 28 [citado 2020 mayo 24]. Disponible en: https://www.argentina.gob.ar/noticias/nue-vos-hallazgos-de-secuenciacion-de-genomas-virales-de-sars-cov2-realizado-por-cientificas.
Lu R, Zhao X, Li J, et al. Ge-nomic characterisation and epide-miology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565–574.
Patel R, Babady E, Theel ES, et al. Report from the American So-ciety for Microbiology COVID-19 International Summit, 23 March 2020: value of diagnostic testing for SARS-CoV-2/COVID-19. mBio. 2020; 11(2):e00722-20.
Udugama B, Kadhiresan P, Kozlowski HN, et al. Diagnosing COVID-19: the disease and tools